Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies

INTRODUCTION: Dimethyl fumarate (DMF) showed favorable benefit-risk in patients with relapsing-remitting multiple sclerosis (MS) in phase 3 DEFINE and CONFIRM trials and in the ENDORSE extension study. Disease activity can differ in younger patients with MS compared with the overall population. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Amezcua, Lilyana, Mao-Draayer, Yang, Vargas, Wendy S., Farber, Rebecca, Schaefer, Sara, Branco, Filipe, England, Sarah M., Belviso, Nicholas, Lewin, James B., Mendoza, Jason P., Shankar, Sai L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195942/
https://www.ncbi.nlm.nih.gov/pubmed/37061656
http://dx.doi.org/10.1007/s40120-023-00475-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195942/
https://www.ncbi.nlm.nih.gov/pubmed/37061656
http://dx.doi.org/10.1007/s40120-023-00475-8

Ejemplares similares